SAT-102 - A low incidence of hepatocellular carcinoma in patients with genotype 1b compensated cirrhosis treated with paritaprevir/ritonavir, ombitasvir and dasabuvir ± ribavirin in a tertiary center: a matter of better selection?

Autor: Chiriac, S., Trifan, A., Stanciu, C., Prelipcean, C.C., Stefanescu, G., Mihai, C., Sfarti, C., Cojocariu, C., Cuciureanu, T., Mihai, F., Singeap, A.M.
Zdroj: In Journal of Hepatology 2017 66(1) Supplement:S630-S630
Databáze: ScienceDirect
Externí odkaz: